Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
449.1 USD | -1.72% | +1.66% | +10.43% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.43% | 118B | |
+10.43% | 106B | |
-10.49% | 23.4B | |
-1.83% | 22.1B | |
-10.16% | 18.34B | |
-41.92% | 16.59B | |
-14.72% | 15.97B | |
+5.87% | 14.03B | |
+16.49% | 11.67B | |
-31.41% | 7.55B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Reiterates FY 2024 Total Product Revenue Guidance of $10.55-$10.75 Billion